First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

DENVER, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

DNA is known to keep its form for centuries, and the researchers found that their tape could store data for more than 345 years at room temperature, or about 20,000 years at 32 degrees Fahrenheit (0 ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.